Foundation Medicine (FMI) Q4 Preliminary Revs $28.8M, Vs. $30.33M Consensus

Go back to Foundation Medicine (FMI) Q4 Preliminary Revs $28.8M, Vs. $30.33M Consensus

Foundation Medicine Reports Preliminary 2016 Results

January 9, 2017 6:30 AM EST

Achieves Total Revenue of Approximately $116.9 Million, a 25% Year Over Year Increase

Reports 43,686 Clinical Tests in 2016, a 32% Year Over Year Increase

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine (NASDAQ: FMI) today announced preliminary unaudited total revenue of approximately $28.8 million in the fourth quarter of 2016 and approximately $116.9 million for the full year ended December 31, 2016, an 11% and 25% increase from the $26.1... More